Anthroponotic Leishmaniasis. Cutaneous leishmaniasis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: inclusion criteria: clinical features of lesion consistent with Anthroponrtic leishmaniasis; specified L. tropica with Molecular method PCR; the patient has indication for local therapy based on clinical judgment; up to 6 months of the lesion duration; the patient already not had any treatment for cutaneous Leishmaniasis; consent for participate in this study. Exclusion Criteria: incompetence for regular follow-up; presence of secondary infection of the lesions based on clinical features and physician judgment; Use of other treatments during the study; Very extensive lesions (more than ten centimeters); presence of necrosis and the lesions deeper than hypodermis; Lesions on the face and joints; having a pacemaker and prosthetic; pregnancies.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lesion healing. Timepoint: Three monthly. Method of measurement: Measuring the size of induration and formidability. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: Three monthly. Method of measurement: Efficacy and side effects including local and systemic reactions will be recorded according to patient's report and clinician observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Mashhad University of Medical Sciences